|
Eine Ebene nach oben |
Gruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 2
2022
Rusconi, Chiara; Cheah, Chan Y.; Eyre, Toby A.; Tucker, David; Klener, Pavel; Gine, Eva; Crucitti, Lara; Muzi, Cristina; Iadecola, Sara; Infante, Gabriele; Bernard, Sophie; Auer, Rebecca L.; Pagani, Chiara; Duglosz-Danecka, Monika; Mocikova, Heidi; Meerten, Tom van; Cencini, Emanuele; Marin-Niebla, Ana; Williams, Michael E.; Angelillo, Piera; Nicoli, Paolo; Arcari, Annalisa; Morello, Lucia; Mannina, Donato; Vitagliano, Orsola; Sartori, Roberto; Chiappella, Annalisa; Sciarra, Roberta; Stefani, Piero M.; Dreyling, Martin; Seymour, John F. und Visco, Carlo
(2022):
Ibrutinib improves survival compared with chemotherapy in mantle cell lymphoma with central nervous system relapse.
In: Blood, Bd. 140, Nr. 17: S. 1907-1916
2019
Visco, Carlo; Tisi, Maria C.; Evangelista, Andrea; Rocco, Alice di; Arcari, Annalisa; Marino, Dario; Merli, Michele; Piazza, Francesco; Gentile, Massimo; Pelosini, Matteo; Loseto, Giacomo; Hermine, Olivier; Dreyling, Martin; Ruggeri, Marco; Martelli, Maurizio; Hoster, Eva; Vitolo, Umberto und Zöllner, Anna‐Katharina
(Juni 2019):
Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death.
In: British Journal of Haematology, Bd. 185, Nr. 5